Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study.
Saved in:
| Title: | Development and comparison of three 89Zr-labeled anti-CLDN18.2 antibodies to noninvasively evaluate CLDN18.2 expression in gastric cancer: a preclinical study. |
|---|---|
| Authors: | Hu, Guilan1, Zhu, Wenjia1, Liu, Yu1, Wang, Yuan1, Zhang, Zheng1, Zhu, Shikun1, Duan, Wenwen2, Zhou, Peipei2, Fu, Chao1, Li, Fang1 lifang@pumch.cn, Huo, Li1 huoli@pumch.cn |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jul2022, Vol. 49 Issue 8, p2634-2644. 11p. 1 Diagram, 1 Chart, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
